Zdrowie i gospodarka · 08/12/2017

FDA Requests Public Comment on Plan to Assess Communication Practices During Drug Development

The Food and Drug Administration (FDA) is seeking public input on a plan to evaluate current communication practices between the FDA and pharmaceutical sponsors during the development of new drugs. This assessment is part of the FDA's performance goals under the Prescription Drug User Fee Act (PDUFA) reauthorization, which aims to improve the efficiency and effectiveness of the drug approval process.